According to the expression of estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptor 2 (HER2), breast cancer is defined as three major subtypes: hormone-receptor (HR) positive, HER2-enriched, and triple-negative breast cancer (TNBC). This evidence concerns the gene ERBB2 and breast carcinoma.